SEC Form 4 · accession 0001437749-15-015512
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tonia L Pankopf
Director
Period of report
Aug 7, 2015
Accepted (ET)
Aug 11, 2015 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 7, 2015 | M | 3,333 | $13.09 | A | 11,048 | D | |
| Common StockF1 | Aug 7, 2015 | M | 2,294 | $13.09 | D | 8,754 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NonQualified Stock Option (Right to Buy)F2 | $13.09 | Aug 7, 2015 | X | 3,333 | A | Dec 13, 2012 | Nov 13, 2019 | Common Stock | 3,333 | 6,667 | D |
Explanation of responses
- F1Ms Pankopf surrendered to the Issuer the right to received an aggregate of 2,294 shares of Common Stock. Ms Pankopf did not sell any shares of Common Stock in connection with the foregoing exercise.
- F2Includes options that have not yet vested but will become fully vested on November 13, 2015.